Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2019
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
Samuel T Wilkinson, Cristan Farmer, Elizabeth D Ballard, et al.
JAMA Psychiatry
|
February 12, 2025
Making Progress in Clinical Trials for Suicide Prevention: A Review
Samuel T Wilkinson, Craig J Bryan, Larry D Alphs, et al.
CNS Drugs
|
August 9, 2023
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Meredith Castro, Samuel T Wilkinson, Rayan K Al Jurdi, et al.
The Journal of Nervous and Mental Disease
|
December 23, 2021
A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With Intent
Jennifer Voelker, Samuel T Wilkinson, Eva G Katz, et al.
Contemporary Clinical Trials
|
March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol
Samuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Depression and Anxiety
|
November 11, 2021
Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta-analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Focus (American Psychiatric Publishing)
|
May 18, 2023
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
The International Journal of Neuropsychopharmacology
|
August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine
Bartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
The Journal of Clinical Psychiatry
|
May 7, 2026
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Samuel T Wilkinson, Brandon M Kitay, Matthew Macaluso, et al.
Psychiatry Research
|
November 7, 2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Brandon M Kitay, Eva Murphy, Matthew Macaluso, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2019
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
Samuel T Wilkinson, Cristan Farmer, Elizabeth D Ballard, et al.
JAMA Psychiatry
|
February 12, 2025
Making Progress in Clinical Trials for Suicide Prevention: A Review
Samuel T Wilkinson, Craig J Bryan, Larry D Alphs, et al.
CNS Drugs
|
August 9, 2023
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Meredith Castro, Samuel T Wilkinson, Rayan K Al Jurdi, et al.
The Journal of Nervous and Mental Disease
|
December 23, 2021
A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With Intent
Jennifer Voelker, Samuel T Wilkinson, Eva G Katz, et al.
Contemporary Clinical Trials
|
March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol
Samuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Depression and Anxiety
|
November 11, 2021
Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta-analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Focus (American Psychiatric Publishing)
|
May 18, 2023
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
The International Journal of Neuropsychopharmacology
|
August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine
Bartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
The Journal of Clinical Psychiatry
|
May 7, 2026
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Samuel T Wilkinson, Brandon M Kitay, Matthew Macaluso, et al.
Psychiatry Research
|
November 7, 2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Brandon M Kitay, Eva Murphy, Matthew Macaluso, et al.
Page
of 11